| mRNA |
dinaciclib |
CTRPv2 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
Bosutinib |
GDSC1000 |
pan-cancer |
AAC |
-0.0057 |
0.9 |
| mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.0058 |
0.9 |
| mRNA |
BRD-K70511574 |
CTRPv2 |
pan-cancer |
AAC |
-0.0051 |
0.9 |
| mRNA |
Vandetanib |
FIMM |
pan-cancer |
AAC |
0.03 |
0.9 |
| mRNA |
JW-7-24-1 |
GDSC1000 |
pan-cancer |
AAC |
0.0046 |
0.9 |
| mRNA |
MS-275 |
GDSC1000 |
pan-cancer |
AAC |
0.0082 |
0.9 |
| mRNA |
SB590885 |
GDSC1000 |
pan-cancer |
AAC |
-0.005 |
0.9 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0054 |
0.9 |
| mRNA |
SB-743921 |
CTRPv2 |
pan-cancer |
AAC |
0.005 |
0.9 |